0001209191-22-013286.txt : 20220225 0001209191-22-013286.hdr.sgml : 20220225 20220225174558 ACCESSION NUMBER: 0001209191-22-013286 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220223 FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kihara James CENTRAL INDEX KEY: 0001816160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 22682507 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-23 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001816160 Kihara James C/O ACADIA PHARMACEUTICALS, INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 Principal Accounting Officer Common Stock 2022-02-23 4 M 0 840 0.00 A 840 D Common Stock 2022-02-23 4 S 0 359 23.80 D 481 D Restricted Stock Units 2022-02-23 4 M 0 840 0.00 A Common Stock 840 2520 D The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in four equal annual installments beginning February 23 2022. /s/ Austin D. Kim, Attorney-in-Fact 2022-02-25